Recent advances in our understanding of neurodegeneration
The DOI matches its Crossref record; 617 of the 618 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are featured by progressive dysfunction and death of cells in selected areas in the nervous system, determining clinical presentation. Neuronal loss is associated with conformational changes in proteins that result in extra- and intra-cellular accumulation of misfolded proteins, representing the hallmarks of many neurodegenerative disorders, summarized as proteinopathies. Intermediate forms such as oligomers and protofibrils are thought to have cytotoxic effects to neurons. Major basic processes, caused by genetic, environmental, and endogenous factors, in addition to abnormal protein dynamics with defective degradation due to deficiency of the ubiquitin-proteosomal-autophagy system, include oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunction, disruption of neuronal Golgi apparatus and transport, molecular chaperones, neurotrophins and "neuroinflammatory" processes. These mechanisms are interrelated in vicious circles finally leading to programmed cell death. A common feature of these conditions is a long run until sufficient protein accumulates, followed by a cascade of symptoms over many years with increasing disability leading to death. This provides a wide therapeutic window, especially in groups at risk identified early and preclinical diagnosis becomes feasible. Neurodegenerative disorders are classified according to known genetic mechanisms or to the major components of protein deposits. Although this has been a productive paradigm for the development of diagnostic consensus criteria, recent molecular biologic and genetic approaches have revealed that there are both overlap and intraindividual diversities between different phenotypes, related to synergistic mechanisms between major pathologic proteins (beta-amyloid, tau, alpha-synuclein, TDP-43), suggesting common pathogenic mechanisms. The nature, time course, and molecular causes of cell degeneration and demise, and the role of various pathogenic factors are a matter of considerable debate, but recent studies have provided insight into the basic processes in neurodegeneration and the roles of cell death programs common to this complex group of disorders, offering new ways for future prevention and treatment strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles are common age-related lesions that are presumed to play primary pathophysiological roles in the dementia of Alzheimer’s disease (AD)(Jellinger, 2009).”
From Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer’s disease (2013) · cites this paper as Jellinger, 2009
Citations
Cites
1 retracted
Items 201–400 of 617
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295 · cited 2×
“pro-inflammatory agent inducing the activation of glia and many of the inflammatory components (Bonifati and Kishore 2007; Farfara et al. 2008; Sondag et al. 2009).”
BackgroundMorphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
Kuusisto, E., Parkkinen, L., & Alafuzoff, I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1241 · Cited by 291 · cited 1×
“The formation of inclusions follows a certain kind of ‘‘maturation’’ pathway and involves ubiquitination only later (Bancher et al. 1989; Kuusisto et al. 2003).”
BackgroundChoi, J., Rees, H. D., Weintraub, S. T., Levey, A. I., Chin, L.-S., & Li, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414327200 · Cited by 291 · cited 1×
“SOD, an enzyme indicative of superoxide generation, shows increase of both isoenzymes (Cu–Zn–SOD and Mn–SOD) in PD SN, in AD and ALS suggesting increased superoxide generation (Choi et al. 2005).”
BackgroundVariants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration
Simpson, C. L., Lemmens, R., Miskiewicz, K., Broom, W. J., Hansen, V. K., van Vught, P. W. J., Landers, J. E., Sapp, P., Van Den Bosch, L., Knight, J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn375 · Cited by 291 · cited 1×
“…abnormal RNA metabolism, mitochondrial dysfunction, defects in axonal transport, growth factor deficiency, astroglial pathology, and glutamate excitotoxicity (Rothstein 2009), abnormal RNA metabolism probably representing a central pathway for motor neuron degeneration (Simpson et al. 2009).”
BackgroundKikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Hisanaga, K., Sato, N., Nunomura, A., Castellani, R. J., Perry, G., Smith, M. A., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0466 · Cited by 289 · cited 1×
“Increased peripheral 8-HOG levels in MSA, AD, and ALS suggest that systemic DNA/RNA oxidation is common in these diseases (Kikuchi et al. 2002).”
BackgroundMPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease
Przedborski, S., Tieu, K., Perier, C., & Vila, M. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041771.66775.d5 · Cited by 287 · cited 2×
“Both contribute to neuronal cell death via decreased protein pumping and reduced voltage differential across the inner mitochondrial membrane inducing not direct opening of the mitochondrial PTP, but rather leading to an increase of the ‘‘releasable’’ soluble pool of cytochrome c in the mitochondrial intermembrane spa…”
BackgroundCell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0309-3 · Cited by 287 · cited 1×
“These include JNK signaling, p53 activation, cell-cycle reactivation, and signaling through Bcl-2 proteins (Levy et al. 2009).”
BackgroundFunctional Consequences of α-Synuclein Tyrosine Nitration
Hodara, R., Norris, E. H., Giasson, B. I., Mishizen-Eberz, A. J., Lynch, D. R., Lee, V. M.-Y., & Ischiropoulos, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408906200 · Cited by 286 · cited 16×
“In a genetic mouse model of PD, 26S proteasomal dysfunction in SN neurons triggers ND of the nigrostriatal pathway, and intraneuronal Lewy-like inclusions containing aSyn and Ub in surviving neurons show mitochondria similar to those in early forms of LBs (pale bodies) in PD patients.”
BackgroundInfluentialEndocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J., & Yarden, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300096200 · Cited by 286 · cited 1×
“Sumoylation and monoubiquitination at one or two lysines within a target protein may also alter the subcellular location of the protein (Mosesson et al. 2003).”
BackgroundJeganathan, S., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2008) · Biochemistry · doi:10.1021/bi800783d · Cited by 286 · cited 1×
“The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments have been discussed (Jeganathan et al. 2008).”
BackgroundJaeger, L. B., Dohgu, S., Sultana, R., Lynch, J. L., Owen, J. B., Erickson, M. A., Shah, G. N., Price, T. O., Fleegal-Demotta, M. A., Butterfiled, D. A., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.01.017 · Cited by 281 · cited 1×
“Inflammation potentially increases brain levels of Ab by three mechanisms: increased influx, decreased efflux, and increased neuronal production (Jaeger et al. 2009).”
BackgroundThe role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease
Wang, X., Su, B., Zheng, L., Perry, G., Smith, M. A., & Zhu, X. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05867.x · Cited by 280 · cited 3×
“Furthermore, it might be possible to reverse polyQ-induced cytotoxicity by preventing mitochondrial fragmentation (Wang et al. 2009a).”
BackgroundHuang, H.-C., & Jiang, Z.-F. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0960 · Cited by 279 · cited 1×
“Accumulation of Ab and phosphotau are thought to be coexistent, Ab initiating hyperphosphorylation of tau (Huang and Jiang 2009).”
BackgroundGiasson, B. I., Ischiropoulos, H., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00804-3 · Cited by 279 · cited 1×
“It can be surmised that oxidative/nitrative stress, which is cooperatively influenced by environmental factors, genetic predisposition, and senescence, may be a link between these disorders (Giasson et al. 2002).”
BackgroundCathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Cullen, V., Lindfors, M., Ng, J., Paetau, A., Swinton, E., Kolodziej, P., Boston, H., Saftig, P., Woulfe, J., Feany, M. B., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-5 · Cited by 279 · cited 1×
“The lysosomal protease cathepsin D influences aSyn processing, aggregation, and toxicity in vivo (Cullen et al. 2009).”
BackgroundLipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 273 · cited 2×
“Keywords Neurodegeneration Classification of proteinopathies Pathogenic factors Oxidative stress Bioenergetic deficiency Mitochondrial defects Neuronal dysfunction/death Abbreviations 8-HOG 8-Hydroxydeoxyguanosine ABAD Ab-binding dehydrogenase Ab b-Amyloid ACD Autophagic cell death AChR Acetylcholine receptor AD Alzhe…”
BackgroundHartmann, A., Troadec, J.-D., Hunot, S., Kikly, K., Faucheux, B. A., Mouatt-Prigent, A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-07-02247.2001 · Cited by 270 · cited 2×
“…mice suggest that activated Csp-3 and -8 represent both vulnerability factors and final effectors in apoptotic death of DAergic neurons (Hartmann et al. 2001a; Turmel et al. 2001), with Bax as a probable cofactor in Csp activation, but could not confirm a control role of Bax in…”
Background-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells
Smith, W. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0482-05.2005 · Cited by 268 · cited 16×
“In a genetic mouse model of PD, 26S proteasomal dysfunction in SN neurons triggers ND of the nigrostriatal pathway, and intraneuronal Lewy-like inclusions containing aSyn and Ub in surviving neurons show mitochondria similar to those in early forms of LBs (pale bodies) in PD patients.”
BackgroundInfluentialMcAlpine, F. E., Lee, J.-K., Harms, A. S., Ruhn, K. A., Blurton-Jones, M., Hong, J., Das, P., Golde, T. E., LaFerla, F. M., Oddo, S., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.006 · Cited by 268 · cited 1×
“Inhibition of soluble TNF signaling in a mouse model of AD prevents/slows pre-plaque amyloid-associated neuropathology, and potentially the progressive neuron ‘‘loss’’ in AD (McAlpine et al. 2009).”
BackgroundDissecting the ER-Associated Degradation of a Misfolded Polytopic Membrane Protein
Nakatsukasa, K., Huyer, G., Michaelis, S., & Brodsky, J. L. (2008) · Cell · doi:10.1016/j.cell.2007.11.023 · Cited by 267 · cited 2×
“Transmembrane proteins at the ER can be degraded by the proteasome, which is assisted by multiple chaperones (Nakatsukasa et al. 2008), but Ub conjugation is not required for the degradation of oxidated proteins by the proteasome (Shringarpure et al.”
BackgroundTo Die or Not to Die: That is the Autophagic Question
Maiuri, M., Galluzzi, L., Vicencio, J., Kepp, O., Tasdemir, E., & Kroemer, G. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769616 · Cited by 267 · cited 9×
“The molecular mechanism involved in the three autophagic pathways: chaperone mediated autophagy (CMA), micro- and macroautophagy, and their relevance in ND have been reviewed recently (Boland et al. 2008; Cherra and Chu 2008; Deretic 2008; Levine and Kroemer 2008; Shacka et al. 2008; Todde et al. 2009).”
BackgroundInfluentialSequestration of iron by Lewy bodies in Parkinson's disease
Castellani, R. J., Siedlak, S. L., Perry, G., & Smith, M. A. (2000) · Acta Neuropathologica · doi:10.1007/s004010050001 · Cited by 265 · cited 3×
“Perturbations of its metabolism are documented in NDDs, associated with abnormalities in copper and calcium homeostasis and redox balance (Castellani et al. 2000; Wojda et al. 2008).”
BackgroundThe ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264 · cited 1×
“In AD, Ab inhibits the proteasome and enhances amyloid and tau accumulation (Oddo 2008; Tseng et al. 2008), while ionic liquids promote amyloid formation from aSyn (Hwang et al. 2009).”
BackgroundButterfield, D. A., & Boyd‐Kimball, D. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00087.x · Cited by 263
The significance of neuroinflammation in understanding Alzheimer’s disease
Eikelenboom, P., Veerhuis, R., Scheper, W., Rozemuller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0575-6 · Cited by 262 · cited 2×
“…and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et al. 2009).”
BackgroundEvidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
Dalfó, E., Portero-Otín, M., Ayala, V., Martínez, A., Pamplona, R., & Ferrer, I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000179050.54522.5a · Cited by 261 · cited 1×
“There is evidence of OS in the neocortex already in incidental LB disease, a subclinicalform of early PD (Dalfo et al. 2005).”
BackgroundParkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
Frank-Cannon, T. C., Tran, T., Ruhn, K. A., Martinez, T. N., Hong, J., Marvin, M., Hartley, M., Treviño, I., O'Brien, D. E., Casey, B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3001-08.2008 · Cited by 261 · cited 2×
“Parkin deficiency increases vulnerability to inflammation-related nigral degeneration (Frank-Cannon et al. 2008), while human neuromelanin induces neuroinflammation and degeneration in the rat SN (Zecca et al. 2008) and aggregated aSyn activates microglia (Zhang et al. 2005b).”
BackgroundA Dynamic Relationship between Intracellular and Extracellular Pools of Aβ
Oddo, S., Caccamo, A., Smith, I. F., Green, K. N., & LaFerla, F. M. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050593 · Cited by 261 · cited 1×
“Lipid surfaces promote aggregation of Ab proteins and the permeability changes that these aggregates induce on lipid membranes (Relini et al. 2009), but there is a dynamic relationship between intra- and extracellular pools of Ab (Oddo et al. 2006).”
BackgroundTabner, B. J., Turnbull, S., El-Agnaf, O. M. A., & Allsop, D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00801-8 · Cited by 260 · cited 2×
“hydroxyl radicals by the addition of Fe(II) by Fenton’s reaction, one of the fundamental mechanisms underlying neurodegenerative processes as a direct sequelae of H2O2 production during the formation of abnormal protein aggregates (Tabner et al. 2002).”
BackgroundIncreased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · cited 1×
“Oxidative damage to nuclear and mtDNA occurs in the earliest detectable phase of AD, PD and HD (Browne and Beal 2006; Nunomura et al. 2001, 2009; Wang et al. 2006), but also in normal aging (Pratico and Sung 2004).”
BackgroundThe Role of Neuroimmunomodulation in Alzheimer's Disease
Maccioni, R. B., Rojo, L. E., Fernández, J. A., & Kuljis, R. O. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03972.x · Cited by 260 · cited 2×
“…of radicals and peroxynitrite attack have been detected in postmortem AD brain, which, at least in part, are produced by activated microglia, and, together with anomalous release of cytokines, may be a progression factor in AD (Block et al. 2007; Maccioni et al. 2009; Weisman et al. 2006).”
BackgroundStolp, H. B., & Dziegielewska, K. M. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 257 · cited 2×
“…and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et al. 2009).”
BackgroundHuntingtin as an essential integrator of intracellular vesicular trafficking
Caviston, J. P., & Holzbaur, E. L. F. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.01.005 · Cited by 257 · cited 2×
“Mitochondria in mutant cells are particularly vulnerable to stresses induced by Ca2? and reactive oxygen species (Lim et al. 2008), and mhtt aggregates impair mitochondrial movement and intracellular vesicular trafficking in cortical neurons (Chang et al. 2006; Caviston and Holzbaur 2009).”
BackgroundMitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Banerjee, R., Starkov, A. A., Beal, M. F., & Thomas, B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.007 · Cited by 253 · cited 1×
“In both s- and f-PD, abnormal mitochondrial paradigms include impaired function of the electron transport chain, damage to mtDNA, impaired calcium buffering, and anomalies in mitochondrial morphology and dynamics (Banerjee et al. 2008).”
BackgroundGlutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity
Jha, N., Jurma, O., Lalli, G., Liu, Y., Pettus, E. H., Greenamyre, J. T., Liu, R.-M., Forman, H. J., & Andersen, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000120200 · Cited by 252 · cited 1×
“Both reduced GSH, an important compound of antioxidative defense and protein repair, and GSH peroxidase activity are decreased in SN of PD and in incidental LB disease (preclinical PD), probably preceding both complex I and DA loss (Jha et al. 2000).”
BackgroundVijayvergiya, C., Beal, M. F., Buck, J., & Manfredi, G. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4385-04.2005 · Cited by 251 · cited 1×
“SOD1 is present in the outer membrane, the intermembrane space, and the mitochondrial matrix, where it forms aggregates, which may contribute to mitochondrial dysfunction (Vijayvergiya et al. 2005).”
BackgroundBenchoua, A., Trioulier, Y., Zala, D., Gaillard, M.-C., Lefort, N., Dufour, N., Saudou, F., Elalouf, J.-M., Hirsch, E., Hantraye, P., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0607 · Cited by 248 · cited 1×
“Mutated htt is aggregated together with Ub in nuclear and cytoplasmic inclusions in human HD and mouse mutants leading to neuronal degeneration (Benchoua et al. 2006).”
BackgroundMechanisms of Aβ mediated neurodegeneration in Alzheimer's disease
Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.013 · Cited by 244 · cited 1×
“…imbalance is met by a series of complex reactions (mitochondrial dysfunction, impaired synaptic transmission, disruption of membrane integrity, impaired axonal transport, etc.) to establish a disease-related homeostasis balance (Crouch et al. 2008; Huber et al. 2007; Nunomura et al. 2006, 2009).”
BackgroundCaspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain
Rohn, T. T., Rissman, R. A., Davis, M. C., Kim, Y. E., Cotman, C. W., & Head, E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0549 · Cited by 243 · cited 2×
“Multiple caspases and elevated mRNA of caspases 1–3 and 5–9 have been detected in postmortem tissue from AD brains (Louneva et al. 2008; Rohn et al. 2002; Stadelmann et al. 1999), see (Ribe et al. 2008).”
BackgroundMitochondrial membrane permeabilization: the sine qua non for cell death
Armstrong, J. S. (2006) · BioEssays · doi:10.1002/bies.20370 · Cited by 243 · cited 2×
“could contribute to cell death by triggering apoptosis, the mitochondrial permeability transition pore (PTP), being crucial in both necrotic and apoptotic cell death, is controlled by antiapoptotic members of the Bax/Bcl-2 family (Armstrong 2006).”
BackgroundMüller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.05.002 · Cited by 243 · cited 1×
“ApoE4 and Ab aggregates were found to act synergistically to induce neurodegeneration in the mouse brain (Belinson et al. 2008), whereas Ab accumulation induced by mutant APP did not (Muller et al. 2008).”
BackgroundRegulation of the apoptosis–necrosis switch
Nicotera, P., & Melino, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207559 · Cited by 241 · cited 2×
“Many of the morphological differences between apoptotic and necrotic processes are thought to be a consequence of the action of cysteine proteases, and recent studies suggest that caspase and calpain functions in cell death are bridging the gap between apoptosis and necrosis (Mattson and Bazan 2006; Nicotera and Melin…”
BackgroundIn Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers
Simoneau, S., Rezaei, H., Salès, N., Kaiser-Schulz, G., Lefebvre-Roque, M., Vidal, C., Fournier, J.-G., Comte, J., Wopfner, F., Grosclaude, J., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030125 · Cited by 240 · cited 1×
“…and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen et al. 2008; Selkoe 2008; Simoneau et al. 2007; Skovronsky et al. 2006; Soto and Estrada 2008; Standridge 2006; Tomiyama et al. 2008).”
BackgroundBiochemical and pathological characterization of Lrrk2
Giasson, B. I., Covy, J. P., Bonini, N. M., Hurtig, H. I., Farrer, M. J., Trojanowski, J. Q., & Van Deerlin, V. M. (2006) · Annals of Neurology · doi:10.1002/ana.20791 · Cited by 238 · cited 2×
“, in LRRK2 mutations (Giasson et al. 2006), in tg mice, and in rare familial forms of DLB (Clarimon et al.”
BackgroundFragmentation of the Golgi apparatus in neurodegenerative diseases and cell death
Gonatas, N. K., Stieber, A., & Gonatas, J. O. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.01.019 · Cited by 236 · cited 2×
“…cytoplasmic dynein, (c) coprecipitation of mutant SOD1 with Hsp25 and Hsp27, (d) reduction of detyrosinated microtubules by aggregated tau which resulted in non-apoptotic cell death, and (e) disruption by mutant growth hormone of the trafficking from the rough ER to the GA (Gonatas et al. 2006).”
BackgroundResende, R., Ferreiro, E., Pereira, C., & Resende de Oliveira, C. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.036 · Cited by 235 · cited 2×
“which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; I…”
BackgroundInflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders
Schwab, C., & McGeer, P. L. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-13402 · Cited by 234 · cited 7×
“…and blood–brain-barrier (BBB) dysfunction are prominent pathological features in the pathogenesis and progression of NDDs including AD (Appel 2009; Eikelenboom et al. 2006; McGeer and McGeer 2005; Rojo et al. 2008; Schwab and McGeer 2008; Stolp and Dziegielewska 2009; Zilka et al. 2009).”
BackgroundInfluentialIntrinsic disorder in proteins associated with neurodegenerative diseases
Uversky, V. (2009) · Frontiers in Bioscience · doi:10.2741/3594 · Cited by 233 · cited 1×
“Many proteins associated with NDDs are intrinsically disordered under physiological conditions (Eliezer 2009b; Uversky 2009).”
BackgroundDeshpande, A., Kawai, H., Metherate, R., Glabe, C. G., & Busciglio, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5980-08.2009 · Cited by 232 · cited 2×
“They affect the postsynaptic region and hippocampal synaptic plasticity (Dinamarca et al. 2008), and their synaptic accumulation correlates with synaptic loss (Deshpande et al. 2009).”
BackgroundVukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232 · cited 1×
“Recent data suggest that JNK-AP1 signaling pathway is responsible for Ab-induced neuroinflammation in cultured human brain endothelial cells and AD brain and that this signaling pathway may serve as a therapeutic target for relieving Ab-induced inflammation (Vukic et al. 2009).”
BackgroundStructure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis
Rakhit, R., & Chakrabartty, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.004 · Cited by 232 · cited 1×
“The two principal hypotheses on the pathogenesis of ALS are: (a) oxidative damage stemming from aberrant SOD1 redox chemistry, and (b) misfolding of the mutant protein (Kabashi and Durham 2006; Rakhit and Chakrabartty 2006).”
BackgroundZuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00111.x · Cited by 231 · cited 1×
“This indicates that, in addition to the reduction in BDNF mRNA, there is also unbalanced neurotrophic receptor signaling in HD (Zuccato and Cattaneo 2007; Zuccato et al. 2008).”
BackgroundFaucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229 · cited 1×
“Sequestration of redox-active iron in LBs of PD SN substantiates the OS hypothesis (Castellani et al. 2000; Faucheux et al. 2003).”
BackgroundLipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229 · cited 1×
“Oxidative damage to nuclear and mtDNA occurs in the earliest detectable phase of AD, PD and HD (Browne and Beal 2006; Nunomura et al. 2001, 2009; Wang et al. 2006), but also in normal aging (Pratico and Sung 2004).”
BackgroundPaleologou, K. E., Kragh, C. L., Mann, D. M. A., Salem, S. A., Al-Shami, R., Allsop, D., Hassan, A. H., Jensen, P. H., & El-Agnaf, O. M. A. (2008) · Brain · doi:10.1093/brain/awn349 · Cited by 228 · cited 2×
“Recently, elevated levels of soluble aSyn oligomers have been detected in postmortem brains of DLB patients (Paleologou et al. 2009) and methods to detect morphologically distinct oligomeric forms of aSyn have been described (Emadi et al. 2009).”
BackgroundAggresome Formation and Neurodegenerative Diseases: Therapeutic Implications
Chin, L., Olzmann, J., & Li, L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330692 · Cited by 227 · cited 1×
“Aggresomes When the capacity of the proteasome system to degrade misfolded proteins is overwhelmed, aggregation occurs and proteins are moved to a Ub-rich structure termed the ‘‘aggresome’’ as a general response to discrepancies in protein turnover (Olzmann et al. 2008).”
BackgroundDisruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta
Pigino, G., Morfini, G., Atagi, Y., Deshpande, A., Yu, C., Jungbauer, L., LaDu, M., Busciglio, J., & Brady, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901229106 · Cited by 227 · cited 1×
“Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal Ab (Pigino et al. 2009).”
BackgroundProteomic Identification of Novel Proteins in Cortical Lewy Bodies
Leverenz, J. B., Umar, I., Wang, Q., Montine, T. J., McMillan, P. J., Tsuang, D. W., Jin, J., Pan, C., Shin, J., Zhu, D., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00048.x · Cited by 226 · cited 1×
“Proteomic analysis of cortical LBs revealed 296 proteins, related to multiple or unknown functions (Leverenz et al. 2007), while in brainstem LBs 90 proteins were identified, differing from Pick bodies and suggesting a complex formation process (Burns et al. 2008).”
BackgroundEffects of overexpression of Huntingtin proteins on mitochondrial integrity
Wang, H., Lim, P. J., Karbowski, M., & Monteiro, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn404 · Cited by 224 · cited 3×
“Furthermore, it might be possible to reverse polyQ-induced cytotoxicity by preventing mitochondrial fragmentation (Wang et al. 2009a).”
BackgroundMandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219 · cited 2×
“Interactions between Ab, aSyn and tau may be a molecular mechanism in overlapping pathology of AD and PD/DLB (Mandal et al. 2006; Obi et al. 2008), probably generated by the same stimulus with the outcome possibly having an inverse relationship depending on genetic background or possibly environmental factors (Fujishi…”
BackgroundFriedreich ataxia: the oxidative stress paradox
Seznec, H., Simon, D., Bouton, C., Reutenauer, L., Hertzog, A., Golik, P., Procaccio, V., Patel, M., Drapier, J.-C., Koenig, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi042 · Cited by 219 · cited 1×
“However, a tg mouse model showed no attenuation of the phenotype after the administration of antioxidants (Seznec et al. 2005).”
BackgroundNeuronal Apoptosis in Neurodegeneration
Okouchi, M., Ekshyyan, O., Maracine, M., & Aw, T. Y. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1511 · Cited by 218 · cited 1×
“…of neuronal demise are discussed: apoptosis, a specific form of gene-directed programmed cell death (PCD); (oncotic) necrosis, a passive killing of the cell; and autophagic degeneration [for rev. see (Bredesen et al. 2006; Bredesen 2008; Gorman 2008; Jellinger 2006, 2007a; Okouchi et al. 2007)].”
BackgroundShelbourne, P. F., Keller-McGandy, C., Bi, W. L., Yoon, S.-R., Dubeau, L., Veitch, N. J., Vonsattel, J. P., Wexler, N. S., Arnheim, N., & Augood, S. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm054 · Cited by 218 · cited 2×
“of which is an expansion of a trinucleotide repeat in the htt gene, the mutation length correlates with cell type-specific vulnerability in HD brain (Shelbourne et al. 2007).”
BackgroundNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216 · cited 2×
“pro-inflammatory agent inducing the activation of glia and many of the inflammatory components (Bonifati and Kishore 2007; Farfara et al. 2008; Sondag et al. 2009).”
BackgroundXia, W., Yang, T., Shankar, G., Smith, I. M., Shen, Y., Walsh, D. M., & Selkoe, D. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.565 · Cited by 216 · cited 1×
“Ab oligomers are increased in AD in both brain tissue and plasma (Xia et al. 2009).”
BackgroundSultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215 · cited 2×
“Keywords Neurodegeneration Classification of proteinopathies Pathogenic factors Oxidative stress Bioenergetic deficiency Mitochondrial defects Neuronal dysfunction/death Abbreviations 8-HOG 8-Hydroxydeoxyguanosine ABAD Ab-binding dehydrogenase Ab b-Amyloid ACD Autophagic cell death AChR Acetylcholine receptor AD Alzhe…”
BackgroundExcitotoxic Neuronal Death and the Pathogenesis of Huntington's Disease
Estrada Sánchez, A. M., Mejía-Toiber, J., & Massieu, L. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.11.011 · Cited by 215 · cited 4×
“A causative link between the formation of protein aggregates and ND has been established, which may occur as a result of the toxic action of substances produced during early phases, and soluble oligomers and protofibrillar derivatives of misfolded proteins may play a pathogenic role (Catalano et al. 2006; Csizmók and…”
BackgroundInfluentialMolecular mechanisms of α-synuclein neurodegeneration
Waxman, E. A., & Giasson, B. I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 213 · cited 2×
“2003); it is potentially prone to misfold (Uversky 2007) and may lead to neuronal death (Kazantsev and Kolchinsky 2008), but also other modes of toxicity have been proposed (Waxman and Giasson 2008).”
Ubiquitin–proteasome system and Parkinson's disease
Olanow, C. W., & McNaught, K. S. P. (2006) · Movement Disorders · doi:10.1002/mds.21013 · Cited by 212 · cited 1×
“…the morphological hallmark of PD and dementia with Lewy bodies (DLB), have a distinct central parkin and Ub-positive domain, with aSyn in the periphery (Olanow and McNaught 2006), but it is incorporated into LBs and dystrophic neurites before ubiquitination (Eliezer 2009a; Sampathu et al. 2003).”
BackgroundNeurotrophins and neurodegeneration
Dawbarn, D., & Allen, S. J. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00487.x · Cited by 210 · cited 3×
“There is growing evidence that reduced neurotrophic support is a significant factor in the pathogenesis of NDDs (Bossers et al. 2009; Dawbarn and Allen 2003) and dementias (Arancio and Chao 2007).”
BackgroundResultCaspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Louneva, N., Cohen, J. W., Han, L.-Y., Talbot, K., Wilson, R. S., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080434 · Cited by 210 · cited 4×
“…with DNA fragmentation particularly in the severely damaged hippocampus, only 0.02–0.05% of neurons display the morphology of apoptosis and show expression of ARPs and of activated caspase 3, the key enzyme of the terminal part of the apoptosis cascade (Louneva et al. 2008; Stadelmann et al. 1999).”
BackgroundInfluentialBeyer, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0104-6 · Cited by 209 · cited 2×
“The latter results in changes of protein size, structure or charge (Beyer 2006), e.g., phosphorylation and nitration, both enhancing fibrillation and formation of LBs (Hodara et al. 2004; Smith et al. 2005).”
BackgroundAβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
Pletnikova, O., West, N., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209 · cited 1×
“Others have suggested that amyloid rather than tau enhances aSyn pathology in human brain and tg mice (Pletnikova et al. 2005).”
BackgroundMitochondrial dysfunction, oxidative stress and neurodegeneration
Mancuso, M., Coppede, F., Migliore, L., Siciliano, G., & Murri, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10110 · Cited by 208 · cited 2×
“Free radical oxygen chemistry plays an important pathogenic role in all these conditions, though it is as yet undetermined what types of oxidative damage occur early in the pathogenic cascade and which ones are secondary manifestation of dying neurons (Emerit et al. 2004; Mancuso et al. 2006; Sayre et al. 2008).”
BackgroundFerrer, I., Blanco, R., Carmona, M., & Puig, B. (2001) · Journal of Neural Transmission · doi:10.1007/s007020100016 · Cited by 207 · cited 1×
“…lipid peroxidation in cerebral cortex (Martinez et al. 2008), increased activity of antioxidant systems, e.g., SOD and GSH, in multiple brain areas (Cantuti-Castelvetri et al. 2002), and activated stress- related proteins, such as SKPK/JNK and p38 SAPK have been described (Ferrer et al. 2001).”
BackgroundDNA Damage and Repair: Relevance to Mechanisms of Neurodegeneration
Martin, L. J. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816ff780 · Cited by 207 · cited 1×
“A decrease in the DNA base excision repair (BER) activity in NDDs suggests that that the brain might be subjected to the double insult of increased DNA damage, as well as deficiencies of DNA repair pathways (Katyal and McKinnon 2007; Martin 2008).”
BackgroundGharibyan, A. L., Zamotin, V., Yanamandra, K., Moskaleva, O. S., Margulis, B. A., Kostanyan, I. A., & Morozova-Roche, L. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.101 · Cited by 206 · cited 1×
“Ab can cause neuronal apoptosis via caspase-dependent and caspase-independent pathways through multiple mechanisms involving mitochondria and ER as the key organelles, disorders of conformational dynamics and DNA integrity (Gharibyan et al. 2007).”
BackgroundZecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205 · cited 2×
“2008), while human neuromelanin induces neuroinflammation and degeneration in the rat SN (Zecca et al. 2008) and aggregated aSyn activates microglia (Zhang et al.”
BackgroundMolecular and cellular aspects of protein misfolding and disease
Herczenik, E., & Gebbink, M. F. B. G. (2008) · The FASEB Journal · doi:10.1096/fj.07-099671 · Cited by 205 · cited 1×
“…d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many, albeit diverse, NDDs (see Herczenik and Gebbink 2008; Jellinger 2007a; Kovacs and Budka 2009; Woulfe 2007).”
BackgroundCo-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Fein, J. A., Sokolow, S., Miller, C. A., Vinters, H. V., Yang, F., Cole, G. M., & Gylys, K. H. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070829 · Cited by 204 · cited 1×
“Although recent data further documented co-localization of Ab and phospho-tau in synaptosomes (Fein et al. 2008), why tau and Ab pathologies are so intimately associated, remains one of the major unresolved questions of AD pathophysiology.”
BackgroundBota, D. A., Ngo, J. K., & Davies, K. J. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.017 · Cited by 203 · cited 1×
“Downregulation of Lon, an ATP-stimulated protease in mitochondria, leads to the accumulation of oxidatively modified proteins in the mitochondrial matrix, which aggregate, followed by apoptosis (Bota et al. 2005).”
BackgroundThe mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
Höglinger, G. U., Lannuzel, A., Khondiker, M. E., Michel, P. P., Duyckaerts, C., Féger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03493.x · Cited by 203 · cited 2×
“2009), but also triggers a cerebral tauopathy (Hoglinger et al. 2005).”
BackgroundOxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203 · cited 1×
“ROS levels appear to be correlated with age, suggesting that oxidative imbalance observed in AD could be due to a decreased total antioxidant capacity (Guidi et al. 2006).”
Backgroundα-Synuclein: Normal Function and Role in Neurodegenerative Diseases
Norris, E. H., Giasson, B. I., & Lee, V. M.-Y. (2004) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)60002-0 · Cited by 202 · cited 1×
“Axonal transport in synucleinopathies aSyn is a highly conserved protein, strongly expressed in neurons and enriched in presynaptic terminals (Norris et al. 2004).”
BackgroundProteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover
Sullivan, P. G., Dragicevic, N. B., Deng, J.-H., Bai, Y., Dimayuga, E., Ding, Q., Chen, Q., Bruce-Keller, A. J., & Keller, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313579200 · Cited by 202 · cited 1×
“On the other hand, proteasomal inhibition reduced mitochondrial complex I and II activities, increased mitochondrial ROS production, and the presence of damaged mitochondria in autophagosomes (Sullivan et al. 2004).”
BackgroundOriglia, N., Righi, M., Capsoni, S., Cattaneo, A., Fang, F., Stern, D. M., Chen, J. X., Schmidt, A. M., Arancio, O., Yan, S. D., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0204-08.2008 · Cited by 202 · cited 1×
“AGE receptors (RAGE) may be a progression factor for Ab-induced cell perturbations (Yan et al. 2009), and neuronal RAGE-mediated activation of p38 mitogen-activated protein kinase (p38 MAPK) contributes to Abmediated cortical synaptic dysfunction (Origlia et al. 2008).”
BackgroundUbiquitin-independent degradation of proteins by the proteasome
Jariel-Encontre, I., Bossis, G., & Piechaczyk, M. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.004 · Cited by 201 · cited 2×
“ubiquitination of protein substrates without proteolysis and proteasome-independent function of Ub in endocytosis and signaling (Mukhopadhyay and Riezman 2007), and Ubindependent degradation of proteins by the proteasome (Jariel-Encontre et al. 2008) have been described, unveiling potential new regulatory functions.”
BackgroundLiu, G., Zhang, C., Yin, J., Li, X., Cheng, F., Li, Y., Yang, H., Uéda, K., Chan, P., & Yu, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.056 · Cited by 201 · cited 1×
“Mitochondrial aSyn dose-dependently down-regulates complex I activity, in vitro impairs mitochondrial function and leads to increased OS (Hsu et al. 2000; Liu et al. 2009).”
BackgroundThe Role of Caspase Cleavage of Tau in Alzheimer Disease Neuropathology
Cotman, C. W., Poon, W. W., Rissman, R. A., & Blurton-Jones, M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.104 · Cited by 199 · cited 2×
“…a link between the development of Ab and NFT/tau pathologies may be due to caspase activation and cleavage of APP which facilitate production of Ab and by cleavage of tau may initiate or accelerate the development of tangle pathology (Cotman et al. 2005; Rohn and Head 2009; Troy and Ribe 2008).”
Backgroundα-Synuclein Misfolding and Neurodegenerative Diseases
Uversky, V. (2008) · Current Protein & Peptide Science · doi:10.2174/138920308785915218 · Cited by 198 · cited 1×
“…is involved in vesicular turnover, synaptic function, neuronal plasticity response, regulation of certain enzymes, transporters and neurotransmitter vesicles, neuronal survival, and can act as molecular chaperone, may be a critical factor of synucleinopathies (Gentile et al. 2008; Uversky 2008).”
BackgroundInflammation in Parkinson's disease.
McGeer, P. L., Yasojima, K., & McGeer, E. G. (2001) · PubMed · Cited by 197
Superoxide dismutase and the death of motoneurons in ALS
Beckman, J. S., Estévez, A. G., Crow, J. P., & Barbeito, L. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01981-0 · Cited by 196 · cited 1×
“Zn-deficient SOD induces apoptosis in motoneurons through a mechanism involving peroxynitrite, which could explain why mitochondrial damage is the earliest marker of injury in ALS–SOD mutant mice (Beckman et al. 2001).”
BackgroundWilms, H., Zecca, L., Rosenstiel, P., Sievers, J., Deuschl, G., & Lucius, R. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780858429 · Cited by 195 · cited 2×
“Demonstration of microglial activation and corresponding DAergic terminal loss in the affected nigrostriatal pathway in early PD supports that neuroinflammatory responses by intrinsic microglia contribute to the progressive degeneration in PD and related diseases (Kim and Joh 2006; Ouchi et al. 2005; Wilms et al. 2007…”
BackgroundNeurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments
Ackerley, S., Thornhill, P., Grierson, A. J., Brownlees, J., Anderton, B. H., Leigh, P. N., Shaw, C. E., & Miller, C. C. J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303138 · Cited by 194 · cited 1×
“Phosphorylation of neurofilament heavy chains (NFHs) also impairs neurofilament axonal transport due to increased pausing of neurofilament movement (Ackerley et al. 2003).”
BackgroundCalcium Homeostasis and Mitochondrial Dysfunction in Striatal Neurons of Huntington Disease
Lim, D., Fedrizzi, L., Tartari, M., Zuccato, C., Cattaneo, E., Brini, M., & Carafoli, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704704200 · Cited by 193 · cited 1×
“Mitochondria in mutant cells are particularly vulnerable to stresses induced by Ca2? and reactive oxygen species (Lim et al. 2008), and mhtt aggregates impair mitochondrial movement and intracellular vesicular trafficking in cortical neurons (Chang et al. 2006; Caviston and Holzbaur 2009).”
BackgroundAutophagy in Neuroprotection and Neurodegeneration: A Question of Balance
Cherra 3rd, S. J., & Chu, C. T. (2008) · Future Neurology · doi:10.2217/14796708.3.3.309 · Cited by 192 · cited 2×
“…mechanism involved in the three autophagic pathways: chaperone mediated autophagy (CMA), micro- and macroautophagy, and their relevance in ND have been reviewed recently (Boland et al. 2008; Cherra and Chu 2008; Deretic 2008; Levine and Kroemer 2008; Shacka et al. 2008; Todde et al. 2009).”
BackgroundThe cytoskeleton in neurodegenerative diseases
Cairns, N. J., Lee, V. M., & Trojanowski, J. Q. (2004) · The Journal of Pathology · doi:10.1002/path.1650 · Cited by 192 · cited 3×
“The mechanism by which aSyn, tau, and Ab protein make fibrils is an example of conformational plasticity, because these polypeptides can visit a coil or helical structure, but otherwise they convert into a pathogenic b-sheet structure highly suitable for polymerization and fiber formation (Cairns et al. 2004; Cookson…”
BackgroundApoptosis-inducing factor: A matter of neuron life and death
Krantic, S., Mechawar, N., Reix, S., & Quirion, R. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.002 · Cited by 192 · cited 1×
“…which mediate mitochondrial dysfunction and subsequent release of pro-apoptotic proteins, such as cytochrome c or apoptosis-inducing factor (AIF), and subsequent caspasedependent and -independent pathways which finally result in degradation of proteins and nuclear DNA (Krantic et al. 2007).”
BackgroundSOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
Banci, L., Bertini, I., Boca, M., Girotto, S., Martinelli, M., Valentine, J. S., & Vieru, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001677 · Cited by 191 · cited 1×
“Structural and dynamic aspects related to oligomerization of SOD1 and its mutants have provided better insight into SOD1 pathway in relation to fALS (Banci et al. 2008, 2009).”
BackgroundEffect of 4-Hydroxy-2-nonenal Modification on α-Synuclein Aggregation
Qin, Z., Hu, D., Han, S., Reaney, S. H., Di Monte, D. A., & Fink, A. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608126200 · Cited by 191 · cited 1×
“Demonstration of hydroxynonenal (HNE) in LBs indicates that peroxidation may play a role in their formation and produce neuronal death due to OS (Qin et al. 2007).”
BackgroundCell death: protein misfolding and neurodegenerative diseases
Nakamura, T., & Lipton, S. A. (2009) · Apoptosis · doi:10.1007/s10495-008-0301-y · Cited by 189 · cited 1×
“Recent studies suggest that generation of excessive NO and ROS, in part due to overactivity of the NMDA-subtype of glutamate receptors, can mediate protein misfolding in the absence of genetic predisposition (Nakamura and Lipton 2009).”
BackgroundCommon molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
Gruzman, A., Wood, W. L., Alpert, E., Prasad, M. D., Miller, R. G., Rothstein, J. D., Bowser, R., Hamilton, R., Wood, T. D., Cleveland, D. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705044104 · Cited by 189 · cited 2×
“In both s- and f-ALS, mitochondrial dysfunction is associated with SOD1 mutation (Gruzman et al. 2007).”
Background(2011) · doi:10.1039/2041-9821 · Cited by 189
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
BARTZOKIS, G., TISHLER, T. A., SHIN, I., LU, P. H., & CUMMINGS, J. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.019 · Cited by 186
Mitochondrial DNA damage and repair in neurodegenerative disorders
Yang, J.-L., Weissman, L., Bohr, V. A., & Mattson, M. P. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.03.012 · Cited by 186 · cited 6×
“…features of both apoptosis and necrosis, but no activated caspases were observed (Andorfer et al. 2005; Schindowski et al. 2008b), while in aging PS/APP mice a crosstalk between apoptosis and autophagy was identified, which influences neuronal survival in AD-related ND (Yang et al. 2008a).”
BackgroundInfluentialTydlacka, S., Wang, C.-E., Wang, X., Li, S., & Li, X.-J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4393-08.2008 · Cited by 184 · cited 1×
“Differential activities of the UPS in neurons (lower) versus glia may account for the preferential accumulation of misfolded proteins (Tydlacka et al. 2008).”
BackgroundWhy have we failed to achieve neuroprotection in Parkinson's disease?
Olanow, C. W., Kieburtz, K., & Schapira, A. H. V. (2009) · Annals of Neurology · doi:10.1002/ana.21461 · Cited by 183
Autophagy–physiology and pathophysiology
Uchiyama, Y., Shibata, M., Koike, M., Yoshimura, K., & Sasaki, M. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0406-y · Cited by 182 · cited 1×
“Tissue-specific impairment of autophagy in CNS tissue causes massive loss of neurons resulting in ND (Uchiyama et al. 2008).”
BackgroundThe role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180 · cited 1×
“OS and damage to mitochondrial DNA during aging impair mitochondrial energy metabolism and ion homeostasis in neurons, thereby rendering them vulnerable to degeneration (Kwong et al. 2006; Lin and Beal 2006; Yang et al. 2008b).”
BackgroundThe PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
Park, J., Lee, G., & Chung, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.086 · Cited by 180 · cited 2×
“Parkin plays a role in maintaining mitochondrial homeostasis, improves mitochondrial dysfunction, regulates their remodeling, promotes their autophagy, promotes DNA repair, and protects against genotoxicity (Kao 2009; Mitsui et al. 2008; Narendra et al. 2008; Park et al. 2009; Poole et al. 2008; Van Laar and Berman 20…”
BackgroundNatural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease
Zhao, B. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9900-9 · Cited by 180 · cited 1×
“Antioxidants may protect neurons in AD and PD, reducing the risk of ND (Head 2009; Zhao 2009).”
BackgroundLEE, H., CASADESUS, G., ZHU, X., TAKEDA, A., PERRY, G., & SMITH, M. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.001 · Cited by 179 · cited 1×
“It has been accepted that misfolding and deposition impairs a gain of function that ultimately leads to neuronal death (Hardy and Selkoe 2002), although there are opponents who challenge this dogma (Lee et al. 2004).”
BackgroundRAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?
Yan, S. D., Bierhaus, A., Nawroth, P. P., & Stern, D. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1030 · Cited by 177 · cited 2×
“AGE receptors (RAGE) may be a progression factor for Ab-induced cell perturbations (Yan et al. 2009), and neuronal RAGE-mediated activation of p38 mitogen-activated protein kinase (p38 MAPK) contributes to Abmediated cortical synaptic dysfunction (Origlia et al.”
BackgroundMitochondria and Huntington's Disease Pathogenesis: Insight from Genetic and Chemical Models
Browne, S. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.018 · Cited by 176
KOTZBAUER, P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.007 · Cited by 176 · cited 1×
“…accumulates during the incubation of Ab or aSyn and hyperphosphorylated tau that show a close interrelationship (Geddes 2005), synergistic action (Mamah et al. 2005; Wenning and Jellinger 2005), and induce a mutual fibrillation (Frasier and Wolozin 2004; Giasson et al. 2003; Kotzbauer et al. 2004).”
BackgroundAll-you-can-eat: autophagy in neurodegeneration and neuroprotection
Jaeger, P. A., & Wyss-Coray, T. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-16 · Cited by 175 · cited 2×
“available to study the role of autophagy in the CNS and how it might be exploited to treat disease (Jaeger and Wyss-Coray 2009).”
BackgroundCaspases, Apoptosis, and Alzheimer Disease: Causation, Correlation, and Confusion
Roth, K. A. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.829 · Cited by 175 · cited 3×
“…of AIFs or death receptors, activators of the caspase/ calpain, Bcl-2 and p53 families, and the mitogen-activated protein kinase pathway that finally induce proteolysis of specific cellular substructures and consequently amplify the death signal cascade (Gorman 2008; Ribe et al. 2008; Roth 2001).”
BackgroundBossers, K., Meerhoff, G., Balesar, R., Van Dongen, J. W., Kruse, C. G., Swaab, D. F., & Verhaagen, J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00171.x · Cited by 173 · cited 3×
“There is growing evidence that reduced neurotrophic support is a significant factor in the pathogenesis of NDDs (Bossers et al. 2009; Dawbarn and Allen 2003) and dementias (Arancio and Chao 2007).”
BackgroundCell systems and the toxic mechanism(s) of α-synuclein
Cookson, M. R., & van der Brug, M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.022 · Cited by 173
DNA repair, mitochondria, and neurodegeneration
Weissman, L., de Souza-Pinto, N. C., Stevnsner, T., & Bohr, V. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.061 · Cited by 172 · cited 2×
“…disturb cell function, cause mtDNA damage, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of NDDs (Andersen 2004; Beal 2007; Mancuso et al. 2008a; Maracchioni et al. 2007; Schapira 2008; Weissman et al. 2007; Yang et al. 2008b).”
BackgroundPower, J. H. T., & Blumbergs, P. C. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0438-3 · Cited by 171 · cited 10×
“TDP-43 Dementia with Lewy bodies (DLB) with TDP- 43 ? inclusions ?”
BackgroundInfluentialAlzheimer disease pathology as a host response
Castellani, R. J., Lee, H.-G., Zhu, X., Perry, G., & Smith, M. A. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318177eaf4 · Cited by 171 · cited 1×
“It becomes more apparent that the pathology of AD and other proteinopathies represents effect rather than cause, or at least a host response to injury equaling neuroprotection (Castellani et al. 2008; Castellani et al. 2009).”
BackgroundUbiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3
Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.289 · Cited by 171 · cited 2×
“Ataxin-3 itself is a target of ubiquitination which may enhance deubiquitinating activity (Todi et al. 2009) and increase mitochondrial DNA models of MJD (Yu et al. 2009b).”
BackgroundCaspase-cleaved Tau Expression Induces Mitochondrial Dysfunction in Immortalized Cortical Neurons
Quintanilla, R. A., Matthews-Roberson, T. A., Dolan, P. J., & Johnson, G. V. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808908200 · Cited by 170 · cited 1×
“Caspase-cleaved tau expression results in mitochondrial dysfunction in cortical neurons via increased calcineurin activity in AD brains (Quintanilla et al. 2009).”
BackgroundReijonen, S., Putkonen, N., Nørremølle, A., Lindholm, D., & Korhonen, L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.025 · Cited by 170 · cited 1×
“The data suggests that compounds targeting ER stress may be considered in designing novel approaches for treatment of HD and possibly other polyQ diseases (Reijonen et al. 2008).”
BackgroundUbiquitination of -synuclein by Siah-1 promotes -synuclein aggregation and apoptotic cell death
Lee, J. T., Wheeler, T. C., Li, L., & Chin, L.-S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm363 · Cited by 170
Impaired ubiquitin–proteasome system activity in the synapses of Huntington's disease mice
Wang, J., Wang, C.-E., Orr, A., Tydlacka, S., Li, S.-H., & Li, X.-J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200709080 · Cited by 169 · cited 1×
“…characterized by striatal degeneration with nuclear inclusions of the truncated ubiquitinated protein huntingtin, chaperones, and proteasomes, where protein quality control regulates polyQ-induced toxicity (Finkbeiner and Mitra 2008; Gil and Rego 2008; Wang et al. 2008; Williams and Paulson 2008).”
BackgroundOPA1-associated disorders: Phenotypes and pathophysiology
Amati‐Bonneau, P., Miléa, D., Bonneau, D., Chevrollier, A., Ferré, M., Guillet, V., Guéguen, N., Loiseau, D., de Crescenzo, M. P., Verny, C., et al. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.04.012 · Cited by 167
Muntané, G., Dalfó, E., Martínez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 165 · cited 1×
“A direct link between hyperphosphorylated tau and synaptic pathology is also supported by accumulation of abnormally phosphorylated tau and aSyn within synaptic terminals in AD brains and APP Swedish mutant tg mice (Muntane et al. 2008; Takahashi et al. 2008).”
BackgroundNeuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease
Yang, D.-S., Kumar, A., Stavrides, P., Peterson, J., Peterhoff, C. M., Pawlik, M., Levy, E., Cataldo, A. M., & Nixon, R. A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071176 · Cited by 164 · cited 6×
“…features of both apoptosis and necrosis, but no activated caspases were observed (Andorfer et al. 2005; Schindowski et al. 2008b), while in aging PS/APP mice a crosstalk between apoptosis and autophagy was identified, which influences neuronal survival in AD-related ND (Yang et al. 2008a).”
BackgroundInfluentialSelective Neuronal Degeneration in Huntington's Disease
(2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75002-5 · Cited by 163 · cited 1×
“In addition to mitochondrial dysfunction, excitotoxic neuronal death related to altered NMDA receptor function induced by mhtt is an important factor in the pathogenesis of HD (Cowan and Raymond 2006; Estrada Sanchez et al. 2008; Fan and Raymond 2007).”
BackgroundLEISSRING, M. A., FARRIS, W., WU, X., CHRISTODOULOU, D. C., HAIGIS, M. C., GUARENTE, L., & SELKOE, D. J. (2004) · Biochemical Journal · doi:10.1042/bj20041081 · Cited by 162 · cited 1×
“Both APP and c-secretase, as well as an isoform of insulin-degrading enzyme, which regulates Ab levels, are present in mitochondria (Leissring et al. 2004).”
BackgroundAmyloid‐β oligomers set fire to inflammasomes and induce Alzheimer's pathology
Salminen, A., Ojala, J., Suuronen, T., Kaarniranta, K., & Kauppinen, A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00496.x · Cited by 162 · cited 1×
“…and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen et al. 2008; Selkoe 2008; Simoneau et al. 2007; Skovronsky et al. 2006; Soto and Estrada 2008; Standridge 2006; Tomiyama et al. 2008).”
BackgroundMolecular basis of programmed cell death involved in neurodegeneration
Krantic, S., Mechawar, N., Reix, S., & Quirion, R. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.09.011 · Cited by 161 · cited 1×
“In acute and chronic neurodegenerative processes newly emerging concepts concerning cell-cycle re-initiation are discussed (Krantic et al. 2005).”
BackgroundUbiquitin-binding domains and their role in the DNA damage response
Hofmann, K. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.003 · Cited by 161 · cited 2×
“…in signal transduction to rival and complement protein phosphorylation (Welchman et al. 2005) and synaptic plasticity (Hegde 2004), while Ub-binding domains (UBD) are relevant to the DNA damage response, acting to restore normal transcription after DNA damage (Daulnyand Tansey 2009; Hofmann 2009).”
BackgroundGunawardena, S., & Goldstein, L. S. B. (2003) · Journal of Neurobiology · doi:10.1002/neu.10319 · Cited by 161 · cited 2×
“In animal models, this was inhibited by infusion with pathological polyglutamine repeats and by disruption of the Drosophila htt gene (Gunawardena and Goldstein 2004).”
BackgroundMolecular motors implicated in the axonal transport of tau and α-synuclein
Utton, M. A., Noble, W. J., Hill, J. E., Anderton, B. H., & Hanger, D. P. (2005) · Journal of Cell Science · doi:10.1242/jcs.02558 · Cited by 158 · cited 1×
“The axonal transport of tau occurs via a mechanism utilizing fast transport motors, including the kinesin family of proteins, and that aSyn transport in neurons may involve both kinesin and dynein motor proteins (Utton et al. 2005).”
BackgroundAmyloid Fibril Formation Can Proceed from Different Conformations of a Partially Unfolded Protein
Calamai, M., Chiti, F., & Dobson, C. M. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.068726 · Cited by 158 · cited 1×
“The resulting aggregates are largely independent of the conformational properties of their soluble precursors (Calamai et al. 2005).”
BackgroundUbiquitin-proteasome-mediated local protein degradation and synaptic plasticity
Hegde, A. N. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.005 · Cited by 157 · cited 2×
“2005) and synaptic plasticity (Hegde 2004), while Ub-binding domains (UBD) are relevant to the DNA damage response, acting to restore normal transcription after DNA damage (Daulnyand Tansey 2009; Hofmann 2009).”
BackgroundNeurotrophins, synaptic plasticity and dementia
Arancio, O., & Chao, M. V. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.03.013 · Cited by 156 · cited 1×
“There is growing evidence that reduced neurotrophic support is a significant factor in the pathogenesis of NDDs (Bossers et al. 2009; Dawbarn and Allen 2003) and dementias (Arancio and Chao 2007).”
BackgroundMolecular chaperones: Multiple functions, pathologies, and potential applications
Alberto J., L. M. (2006) · Frontiers in bioscience · doi:10.2741/2257 · Cited by 156
Imaging microglial activation in Huntington's disease
Tai, Y., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. P. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.10.029 · Cited by 155 · cited 1×
“…play a major role in the pathogenesis of HD has been shown to correlate with severity of the disease, with a close spatial and temporal relationship to neuronal dysfunction (Pavese et al. 2006; Tai et al. 2007a), and has already been detected in presymptomatic HD gene carriers (Tai et al. 2007b).”
BackgroundAmyloid-β immunisation for Alzheimer's disease
Wisniewski, T., & Konietzko, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70170-4 · Cited by 155 · cited 1×
“…models treated by immunotherapy causing plaque removal and increase in severity of cerebral amyloid angiopathy (CAA) (Boche et al. 2008; Boche and Nicoll 2008; Holmes et al. 2008; Prada et al. 2007; Wilcock et al. 2004; Wisniewski and Konietzko 2008) are not discussed here (see Foster et al. 2009).”
BackgroundIs Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
Hartmann, A., Michel, P. P., Troadec, J., Mouatt‐Prigent, A., Faucheux, B. A., Ruberg, M., Agid, Y., & Hirsch, E. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00160.x · Cited by 153 · cited 2×
“…mice suggest that activated Csp-3 and -8 represent both vulnerability factors and final effectors in apoptotic death of DAergic neurons (Hartmann et al. 2001a; Turmel et al. 2001), with Bax as a probable cofactor in Csp activation, but could not confirm a control role of Bax in…”
BackgroundInclusion bodies: Specificity in their aggregation process and amyloid-like structure
Morell, M., Bravo, R., Espargaró, A., Sisquella, X., Avilés, F. X., Fernàndez‐Busquets, X., & Ventura, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.06.007 · Cited by 153 · cited 2×
“aggregation exhibits a remarkable specificity, suggesting that conserved mechanisms underlie it depending on selective interactions and result in the formation of fibrillary structures (Morell et al. 2008).”
BackgroundSampathu, D. M., Giasson, B. I., Pawlyk, A. C., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63633-4 · Cited by 152 · cited 2×
“…the morphological hallmark of PD and dementia with Lewy bodies (DLB), have a distinct central parkin and Ub-positive domain, with aSyn in the periphery (Olanow and McNaught 2006), but it is incorporated into LBs and dystrophic neurites before ubiquitination (Eliezer 2009a; Sampathu et al. 2003).”
BackgroundSynaptic memory mechanisms: Alzheimer's disease amyloid β-peptide-induced dysfunction
Rowan, M. J., Klyubin, I., Wang, Q., Hu, N. W., & Anwyl, R. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351219 · Cited by 152 · cited 1×
“…2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen et al. 2008; Selkoe 2008; Simoneau et al. 2007; Skovronsky et al. 2006; Soto and Estrada 2008; Standridge 2006; Tomiyama…”
BackgroundCo-occurrence of Alzheimer's disease β-amyloid and tau pathologies at synapses
Takahashi, R. H., Capetillo-Zarate, E., Lin, M. T., Milner, T. A., & Gouras, G. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.021 · Cited by 150
DNA Damage and Repair in Alzheimers Disease
Coppede, F., & Migliore, L. (2009) · Current Alzheimer Research · doi:10.2174/156720509787313970 · Cited by 148 · cited 2×
“Mitochondrial dysfunction in Alzheimer and Parkinson disease There is evidence of impaired DNA repair in both the aging brain and AD (Katyal and McKinnon 2008), suggesting that this may play a role in AD pathogenesis (Coppede and Migliore 2009).”
BackgroundRNA oxidation in Alzheimer disease and related neurodegenerative disorders
Nunomura, A., Hofer, T., Moreira, P. I., Castellani, R. J., Smith, M. A., & Perry, G. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0508-1 · Cited by 148 · cited 5×
“…imbalance is met by a series of complex reactions (mitochondrial dysfunction, impaired synaptic transmission, disruption of membrane integrity, impaired axonal transport, etc.) to establish a disease-related homeostasis balance (Crouch et al. 2008; Huber et al. 2007; Nunomura et al. 2006, 2009).”
BackgroundInfluentialKristiansen, M., Messenger, M. J., Klöhn, P.-C., Brandner, S., Wadsworth, J. D. F., Collinge, J., & Tabrizi, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506600200 · Cited by 148 · cited 2×
“2003), the formation of which has been associated with activation of caspases and apoptosis (Kristiansen et al. 2005).”
BackgroundHereditary Ferritinopathy: A Novel Mutation, Its Cellular Pathology, and Pathogenetic Insights
Mancuso, M., Davidzon, G., Kurlan, R. M., Tawil, R., Bonilla, E., Di Mauro, S., & Powers, J. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.4.280 · Cited by 146
Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
Bharadwaj, P. R., Dubey, A. K., Masters, C. L., Martins, R. N., & Macreadie, I. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00609.x · Cited by 146 · cited 1×
“The structure of a soluble Ab-peptide oligomer has recently been characterized (Yu et al. 2009a) and cell culture studies with recombinant-derived or chemically synthesized Ab have contributed to a better understanding of Ab oligomerization (Bharadwaj et al. 2009).”
BackgroundRohn, T. T., Vyas, V., Hernandez-Estrada, T., Nichol, K. E., Christie, L.-A., & Head, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5620-07.2008 · Cited by 146 · cited 2×
“, the Bcl-2 protein family, involved in the progression of the apoptotic cascade that are relevant to AD (Rohn et al. 2008).”
BackgroundMitochondrial DNA Mutations in Disease, Aging, and Neurodegeneration
Reeve, A. K., Krishnan, K. J., & Turnbull, D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.016 · Cited by 145 · cited 1×
“Whether these change are a secondary consequence of other factors or whether they cause eventual cell death is unknown (Reeve et al. 2008).”
BackgroundWhat causes cell death in Parkinson's disease?
Gupta, A., Dawson, V. L., & Dawson, T. M. (2009) · Annals of Neurology · doi:10.1002/ana.21573 · Cited by 143 · cited 2×
“…and COX, a key enzyme of the mitochondrial respiratory chain, suggests that aSyn aggregation may contribute to enhanced mitochondrial dysfunction (Gupta et al. 2008). aSyn is a central regulator of DA life cycle, and as an effector of DA-dependent OS may have a role in both neurodegeneration…”
BackgroundALS and FTLD: two faces of TDP‐43 proteinopathy
Liscic, R. M., Grinberg, L. T., Zidar, J., Gitcho, M. A., & Cairns, N. J. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02195.x · Cited by 143 · cited 1×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundThe role of tau phosphorylation and cleavage in neuronal cell death
Chun, W. (2007) · Frontiers in Bioscience · doi:10.2741/2097 · Cited by 142 · cited 2×
“…neurotoxicity of early aggregated state (before fibril formation and after hyperphosphorylation), contributing to disruption of neuronal circuits due to synapse loss and eventual cell death (Chun and Johnson 2007; Mondragon-Rodriguez et al. 2009; Spires-Jones et al. 2009; Takashima 2008).”
BackgroundTakeuchi, H., Kobayashi, Y., Ishigaki, S., Doyu, M., & Sobue, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209356200 · Cited by 141 · cited 1×
“Overexpression of HSP 70 and 40 in the presence of mutant SOS-1 in a cell model results in synergistic reduction of aggregate formation (Takeuchi et al. 2002).”
BackgroundMitochondrial dynamics in Parkinson's disease
Van Laar, V. S., & Berman, S. B. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 140 · cited 3×
“Central to apoptotic cell death is the caspase family of proteases that are grouped on the basis of their activities into effector and initiator caspases [for rev. see (Ribe et al. 2008; Ribe Garrido et al. 2009)], while common players in necrotic cell death, irrespective of the stimulus, are calcium and ROS (Vanlange…”
BackgroundChaperone signalling complexes in Alzheimer's disease
Koren, J., Jinwal, U. K., Lee, D. C., Jones, J. R., Shults, C. L., Johnson, A. G., Anderson, L. J., & Dickey, C. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00557.x · Cited by 138
TDP-43: a novel neurodegenerative proteinopathy
Forman, M. S., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2007.08.005 · Cited by 138 · cited 2×
“? a Kovacs et al. 2008; b Forman et al. 2007, Liscic et al. 2008, Neumann et al. 2009b; c Farrer et al. 2009; d Kwiatkowski et al. 2009; e Rollinson et al. 2009; f Sreedharan and Shaw 2009 misfolded proteins with formation of high-ordered insoluble fibrils are common pathological hallmarks of many,…”
BackgroundMitochondria and Neurodegeneration
Petrozzi, L., Ricci, G., Giglioli, N. J., Siciliano, G., & Mancuso, M. (2007) · Bioscience Reports · doi:10.1007/s10540-007-9038-z · Cited by 137
Oxidative Damage and Cognitive Dysfunction: Antioxidant Treatments to Promote Healthy Brain Aging
Head, E. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9808-4 · Cited by 135 · cited 2×
“…a link between the development of Ab and NFT/tau pathologies may be due to caspase activation and cleavage of APP which facilitate production of Ab and by cleavage of tau may initiate or accelerate the development of tangle pathology (Cotman et al. 2005; Rohn and Head 2009; Troy and Ribe 2008).”
BackgroundThe autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy
Shacka, J. (2008) · Frontiers in Bioscience · doi:10.2741/2714 · Cited by 134 · cited 2×
“…mechanism involved in the three autophagic pathways: chaperone mediated autophagy (CMA), micro- and macroautophagy, and their relevance in ND have been reviewed recently (Boland et al. 2008; Cherra and Chu 2008; Deretic 2008; Levine and Kroemer 2008; Shacka et al. 2008; Todde et al. 2009).”
BackgroundLin, W.-L., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0408-9 · Cited by 134
Borland, M. K., Trimmer, P. A., Rubinstein, J. D., Keeney, P. M., Mohanakumar, K., Liu, L., & Bennett, J. P. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-21 · Cited by 134 · cited 2×
“2008), while subacute rotenone treatment of SH-SY5Y neuroblastoma cells reproduced Lewy neurites but not LB inclusions, reduces mitochondrial movement and slowly killed neural cells (Borland et al. 2008).”
BackgroundRole of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders
Layfield, R., Cavey, J. R., & Lowe, J. S. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00025-4 · Cited by 133 · cited 1×
“Ubiquitination of proteins in inclusions may also be part of a signal transduction mechanism in afflicted neurons and do not reflect abortive proteolysis (Layfield et al. 2003).”
BackgroundmicroRNAs in neurodegeneration
Bushati, N., & Cohen, S. M. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.07.001 · Cited by 133 · cited 2×
“…(miRNAs), brain-enriched, small noncoding RNAs that participate in RNA translational and protein expression regulation, has been emphasized, suggesting their involvement in the emergence or progression of NDDs (Bushati and Cohen 2008; Nelson et al. 2008), including AD (Cogswell et al. 2008).”
BackgroundStructural and dynamic aspects related to oligomerization of apo SOD1 and its mutants
Banci, L., Bertini, I., Boca, M., Calderone, V., Cantini, F., Girotto, S., & Vieru, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809845106 · Cited by 132 · cited 1×
“Structural and dynamic aspects related to oligomerization of SOD1 and its mutants have provided better insight into SOD1 pathway in relation to fALS (Banci et al. 2008, 2009).”
BackgroundMitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 131 · cited 3×
“2008), but whether mitochondrial dysfunction is a primary or secondary event, or part of a multifactorial pathogenic process remains to be elucidated (Przedborski 2009; Schapira 2009; Vila et al. 2008).”
BackgroundLafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 131 · cited 1×
“…by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez and Avila 2008; Kayed et al. 2003; Lafaye et al. 2009; Moore et al. 2009; Truant et al. 2008; Williams and Paulson 2008) (Fig.”
Regulation and interplay of apoptotic and non‐apoptotic cell death
Kim, R., Emi, M., Tanabe, K., Murakami, S., Uchida, Y., & Arihiro, K. (2006) · The Journal of Pathology · doi:10.1002/path.1885 · Cited by 130 · cited 2×
“In a number of different models, caspase inhibition does not maintain cellular viability and instead shifts the morphology of death from apoptosis to nonapoptotic pathways (Kim et al. 2006).”
BackgroundKokubo, H., Kayed, R., Glabe, C. G., & Yamaguchi, H. (2004) · Brain Research · doi:10.1016/j.brainres.2004.10.041 · Cited by 130 · cited 1×
“…(Catalano et al. 2006; Csizmók and Tompa 2009; Gong et al. 2003; Haass and Selkoe 2007; Hu et al. 2008; Irvine et al. 2008; Israeli and Sharon 2009; Kokubo et al. 2005; Lee et al. 2006; Resende et al. 2008; Rowan et al. 2007; Salminen et al. 2008; Selkoe 2008; Simoneau et al. 2007; Skovronsky et…”
BackgroundAlzheimer’s disease and NGF signaling
Salehi, A., Delcroix, J., & Swaab, D. (2004) · Journal of neural transmission · doi:10.1007/s00702-003-0091-x · Cited by 128 · cited 1×
“Decreased retrograde transport of NGF in human brain and mouse models leads to loss of neuronal markers and shrinkage of neurons in the cholinergic basal forebrain, rather than due to decreased synthesis (Salehi et al. 2004).”
BackgroundFatty Acid Oxidation in the Pathogenesis of Alzheimer's Disease
Montine, T. J., & Morrow, J. D. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62347-4 · Cited by 128 · cited 1×
“Major components are lipid and protein peroxidation, glycosidation with DNA oxidation and formation of advanced glycation end products (AGEs), protein-bound oxidation products of sugar (Montine and Morrow 2005; Reddy et al. 2002).”
BackgroundTDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis
Kwong, L. K., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Neurosignals · doi:10.1159/000109758 · Cited by 127 · cited 1×
“TDP-43 proteinopathies are distinct from most other NDDs because they are due to protein misfolding without amyloidosis, while TDP-43positive inclusions show abnormal hyperphosphorylation, ubiquitination and C-terminal fragments (Kwong et al. 2008).”
BackgroundGeneral aspects of neurodegeneration
Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126 · cited 1×
“…are considered multifactorial caused by genetic, environmental, and endogenous factors related to aging, but their pathogenic role and their basic molecular mechanisms are not fully understood (Forman et al. 2004; Jellinger 2003, 2007a; Ovádi and Orosz 2009; Selkoe 2004; Skovronsky et al. 2006).”
BackgroundSelf-citationAutophagy in neurodegeneration and development
Winslow, A. R., & Rubinsztein, D. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.010 · Cited by 126 · cited 2×
“…vacuoles, endocytosis, enlargement of the GA as a source of lysosomes providing hydrolytic enzymes for the vacuolization of the ER, and moderate condensation of nuclear chromatin that may ultimately leave the pyknotic nuclei and is destroyed by autophagosomes (Winslow and Rubinsztein 2008).”
BackgroundBrunden, K. R., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14406 · Cited by 125 · cited 2×
“Oligomeric and pre-aggregated forms of tau protein have been shown to be toxic in vitro (Khlistunova et al. 2006), but the mechanisms underlying its structural changes leading to human tauopathies still remain elusive (Brunden et al. 2008; Sahara et al. 2008).”
BackgroundProtein folding diseases and neurodegeneration: Lessons learned from yeast
Winderickx, J., Delay, C., Vos, A. D., Klinger, H., Pellens, K., Vanhelmont, T., LEUVEN, F. V., & Zabrocki, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.020 · Cited by 125 · cited 2×
“Due to the involvement of critical conformational changes of proteins, these disorders are often denoted as ‘‘protein misfolding’’ diseases (Gregersen 2006; Winderickx et al. 2008) or proteinopathies (Forman et al.”
BackgroundPhagocytosis of Amyloid-β and Inflammation: Two Faces of Innate Immunity in Alzheimer's Disease
Fiala, M., Cribbs, D. H., Rosenthal, M., & Bernard, G. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11406 · Cited by 124 · cited 1×
“Increased pro-inflammatory cytokine levels and activated microglia and macrophages may be a compensation for defective clearance of Ab (Fiala et al. 2007).”
BackgroundFujita, Y., Ohama, E., Takatama, M., Al‐Sarraj, S., & Okamoto, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0114-4 · Cited by 124 · cited 1×
“…that neuronal Golgi fragmentation is an early and probably irreversible lesion in ND, e.g., in nigral neurons with aSyn-positive inclusions in PD (Fujita et al. 2006), caused by a variety of mechanisms including accumulation of misfolded proteins. aSyn has been shown to block ER Golgi traffic…”
BackgroundDeregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction
Sun, K., De Pablo, Y., Vincent, F., & Shah, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05616.x · Cited by 122 · cited 4×
“…protein kinase pathways triggered by OS, are excessively activated in AD (Johnson and Bailey 2003; Petersen et al. 2007), even in early stages, deregulating cyclin-dependent kinase 5 (Cdk5), compromising the cellular antioxidant defense system and causing mitochondrial damage (Sun et al. 2008).”
BackgroundInfluentialPhospholipases A2Mediate Amyloid-β Peptide-Induced Mitochondrial Dysfunction
Zhu, D., Lai, Y., Shelat, P. B., Hu, C., Sun, G. Y., & Lee, J. C.-M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3505-06.2006 · Cited by 119 · cited 1×
“Mitochondrial dysfunction in AD is caused by phospholipase-2-mediated oligomeric Ab, leading to impairment of ATP production and increase of OS in AD brain (Zhu et al. 2006).”
BackgroundProtein aggregation, metals and oxidative stress in neurodegenerative diseases
Tabner, B. J., El-Agnaf, O. M. A., German, M. J., Fullwood, N. J., & Allsop, D. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331082 · Cited by 117 · cited 1×
“Increased levels of oxidative damage to DNA, lipids, and proteins have been detected in postmortem tissues from patients with PD, AD, ALS, PSP, and related disorders, and some of these changes may occur early in disease progression (Tabner et al. 2005).”
BackgroundA role for ubiquitin in the clearance of nonfunctional rRNAs
Fujii, K., Kitabatake, M., Sakata, T., Miyata, A., & Ohno, M. (2009) · Genes & Development · doi:10.1101/gad.1775609 · Cited by 116 · cited 4×
“Other related mitochondrial encephalopathies are MERFF (myoclonus epilepsy and ragged-red fibers) with mental deterioration and myopathy, due to the mutation of an A-to-C transition at nucleotide 8,344 in the mtRNA-Lys gene or rare mutations in tRNAser gene, or MELAS (mitochondrial myopathy, encephalopathy, lactic aci…”
BackgroundInfluentialThe Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity
Hoe, H.-S., Fu, Z., Makarova, A., Lee, J.-Y., Lu, C., Feng, L., Pajoohesh-Ganji, A., Matsuoka, Y., Hyman, B. T., Ehlers, M. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900141200 · Cited by 115 · cited 2×
“Presynaptic injection of Ab blocks synaptic transmission (Moreno et al. 2009), while postsynaptic APP has recently been shown to enhance N-methyl D-aspartate (NMDA) receptors (Hoe et al. 2009).”
BackgroundUbiquitination of α-synuclein and autophagy in Parkinson's disease
Engelender, S. (2008) · Autophagy · doi:10.4161/auto.5604 · Cited by 114
Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models
Sonnen, J. A., Breitner, J. C. S., Lovell, M. A., Markesbery, W. R., Quinn, J. F., & Montine, T. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.022 · Cited by 113 · cited 2×
“In both human AD and transgenic (tg) mouse models of AD, oxidative damage occurs preceding Ab deposition that further contributes to OS and ND (Butterfield and BoydKimball 2004; Pratico et al. 2001; Sonnen et al. 2008).”
BackgroundUse of p62/SQSTM1 antibodies for neuropathological diagnosis
Kuusisto, E., Kauppinen, T., & Alafuzoff, I. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00884.x · Cited by 113 · cited 1×
“This small stress-induced protein is found in various inclusions of NDDs, and the Ubbinding protein 62/sequestosome 1, a cytosolic 62-kd protein (p62) is also a common component of various inclusions (Kuusisto et al. 2008; Wooten et al. 2006).”
BackgroundWooten, M. W., Hu, X., Babu, J. R., Seibenhener, M. L., Geetha, T., Paine, M. G., & Wooten, M. C. (2006) · BioMed Research International · doi:10.1155/jbb/2006/62079 · Cited by 113 · cited 1×
“This small stress-induced protein is found in various inclusions of NDDs, and the Ubbinding protein 62/sequestosome 1, a cytosolic 62-kd protein (p62) is also a common component of various inclusions (Kuusisto et al. 2008; Wooten et al. 2006).”
BackgroundAutoantibodies against β‐amyloid are common in Alzheimer's disease and help control plaque burden
Kellner, A., Matschke, J., Bernreuther, C., Moch, H., Ferrer, I., & Glatzel, M. (2009) · Annals of Neurology · doi:10.1002/ana.21475 · Cited by 113 · cited 1×
“Autoantibodies against Ab are common in AD brain and help control the plaque burden (Kellner et al. 2009).”
BackgroundAlpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 112 · cited 1×
“Induction of hyperphosphorylation of tau by aSyn in the 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) model of parkinsonism (Duka et al. 2006), and the co-location of phospho-tau and aSyn in both NFTs and LBs (Ishizawa et al. 2003; Shao et al. 2006) and the co-occurrence of abnormal deposition…”
BackgroundCaspase‐3 activation in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated mice
Turmel, H., Hartmann, A., Parain, K., Douhou, A., Srinivasan, A. N., Agid, Y., & Hirsch, É. C. (2001) · Movement Disorders · doi:10.1002/mds.1037 · Cited by 111 · cited 2×
“…that activated Csp-3 and -8 represent both vulnerability factors and final effectors in apoptotic death of DAergic neurons (Hartmann et al. 2001a; Turmel et al. 2001), with Bax as a probable cofactor in Csp activation, but could not confirm a control role of Bax in apoptotic death of DA neurons…”
BackgroundTruant, R., Atwal, R. S., Desmond, C., Munsie, L., & Tran, T. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06561.x · Cited by 111 · cited 3×
“The ‘‘toxic oligomer’’ hypothesis is supported by the finding that a single-domain antibody can recognize a common conformational epitope that is displayed by several disease-associated proteins, including b-amyloid (Ab), a-synuclein (aSyn), tau protein, prions, and polyglutamine (polyQ) containing peptides (Hernandez…”
BackgroundThe Role of α‐Synuclein in Both Neuroprotection and Neurodegeneration
SIDHU, A., WERSINGER, C., MOUSSA, C. E., & VERNIER, P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.016 · Cited by 111 · cited 1×
“…respiratory chain, suggests that aSyn aggregation may contribute to enhanced mitochondrial dysfunction (Gupta et al. 2008). aSyn is a central regulator of DA life cycle, and as an effector of DA-dependent OS may have a role in both neurodegeneration and neuroprotection (Sidhu et al. 2004).”
BackgroundInvolvement of maillard reactions in Alzheimer disease
Reddy, V. P., Obrenovich, M. E., Atwood, C., Perry, G. L., & Smith, M. A. (2002) · Neurotoxicity Research · doi:10.1080/1029840290007321 · Cited by 110 · cited 1×
“Major components are lipid and protein peroxidation, glycosidation with DNA oxidation and formation of advanced glycation end products (AGEs), protein-bound oxidation products of sugar (Montine and Morrow 2005; Reddy et al. 2002).”
BackgroundPeripheral Chemokine Receptors, Their Ligands, Cytokines and Alzheimer's Disease
Reale, M., Iarlori, C., Feliciani, C., & Gambi, D. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14203 · Cited by 109 · cited 2×
“The patterns of cytochemokine involvement strengthen the inflammatory theory of AD and raise a pathophysiologic role for selective alteration of cytochemokine network (Reale et al. 2008).”
BackgroundDoes the mitochondrial genome play a role in the etiology of Alzheimer’s disease?
Elson, J. L., Herrnstadt, C., Preston, G., Thal, L. J., Morris, C. M., Edwardson, J. A., Beal, M. F., Turnbull, D. M., & Howell, N. (2006) · Human Genetics · doi:10.1007/s00439-005-0123-8 · Cited by 109 · cited 1×
“However, recent studies indicated that pathogenic-inherited mDNA mutations do not constitute a major etiological factor in sporadic AD or may even reduce the risk of AD (Elson et al. 2006).”
Background
Research works printed but not linked: 2
- Mattson P, Bazan NG (2006) Apoptosis and necrosis. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 603–615
- Morfini GA, Stenoien DL, Brady ST (2006) Axonal transport. In: Siegel GJ, Albers RW, Brady ST, Price DL (eds) Basic neurochemistry, 7th edn. Elsevier Academic Press, Amsterdam, pp 485–501
Cited by
KEGG: integrating viruses and cellular organisms
Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M., & Tanabe, M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa970 · Cited by 3,436
Microalgae for High-Value Products Towards Human Health and Nutrition
Barkia, I., Saari, N., & Manning, S. R. (2019) · Marine Drugs · doi:10.3390/md17050304 · Cited by 719
“This is supported by the overproduction of ROS in early-stage patients that results in cleaving and misfolding of the amyloid precursor protein to amyloid beta-peptide (Aβ), which induces mitochondrial dysfunction and facilitates the formation of amyloid plaques [230].”
BackgroundPhotoreceptor degeneration: genetic and mechanistic dissection of a complex trait
Wright, A. F., Chakarova, C. F., Abd El-Aziz, M. M., & Bhattacharya, S. S. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2717 · Cited by 631
“Integrating diverse cellular stresses Some themes, such as increased RONS and bioenergetic dysfunction, recur in the PR cell-death mechanisms discussed above, but how do the different mechanisms converge on a final common death pathway? Similar mechanistic themes have been identified for neurodegenerative disorders th…”
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
“1 Algorithm for classification of neurodegenerative diseases with protein deposits (proteinopathies) (from [1]).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Jellinger, K. A.
- Corresponding author
- Jellinger, Kurt A.
- ORCID
- Jellinger, Kurt A.
- Venue
- Journal of Neural Transmission
- Published
- 2009-06-05
- Volume
- 116
- Issue
- 9
- Pages
- 1111-1162
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2091026347
- Cited by
- 274
- References
- 618
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 13 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 13 · 2014: 12 · 2013: 27 · 2012: 23
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neurodegeneration, proteinopathies, protein misfolding, ubiquitin-proteasome system, autophagy, oxidative stress, mitochondrial dysfunction, Golgi apparatus, molecular chaperones, neurotrophins, neuroinflammation, programmed cell death, amyloid-beta, tau protein, alpha-synuclein, TDP-43, preclinical diagnosis, common pathogenic mechanisms, neurodegenerative disease classification
- MeSH terms
- Free Radicals, Humans, Models, Biological, Mutation, Nerve Tissue Proteins, Protein Folding, Oxidative Stress, Neurodegenerative Diseases, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.